Literature DB >> 6681715

Importance, localization and functional properties of the cell-associated form of plasminogen activator in mouse peritoneal macrophages.

G Lemaire, J C Drapier, J F Petit.   

Abstract

In inflammatory macrophages, plasminogen activator exists in two active forms, a soluble form released into the extracellular medium and a cell-associated form. This communication describes some properties of the cellular form of plasminogen activator, in intact macrophages and in cell lysates. Cellular plasminogen activator is a membrane protein, associated with the outer face of the plasma membrane; in intact macrophages, it participates in the activation of exogenous plasminogen and, thus, has to be considered as an ectoenzyme. A plasminogen activator activity can be detected in cell lysates (macrophage monolayers lysed in 0.1% Triton X-100) only when plasmin production is followed by the use of small synthetic substrates because a soluble inhibitor, released during extraction, blocks plasmin fibrinolytic activity. In these lysates, plasminogen activator molecules exist as high molecular weight unstable complexes exhibiting a high affinity for plasminogen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6681715     DOI: 10.1016/0304-4165(83)90235-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.

Authors:  H A Chapman; O L Stone
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

Review 2.  Studies on rat mammary adenocarcinomas: a model for metastasis.

Authors:  I A Ramshaw; P Badenoch-Jones
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 3.  Effects of exogenous amines on mammalian cells, with particular reference to membrane flow.

Authors:  R T Dean; W Jessup; C R Roberts
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

4.  Cellular and secreted tumor plasminogen activator: the effects of NaCl.

Authors:  P Badenoch-Jones; I A Ramshaw; A Grant
Journal:  Experientia       Date:  1986-04-15

5.  Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.

Authors:  J Pöllänen; O Saksela; E M Salonen; P Andreasen; L Nielsen; K Danø; A Vaheri
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

6.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.

Authors:  J D Vassalli; D Baccino; D Belin
Journal:  J Cell Biol       Date:  1985-01       Impact factor: 10.539

7.  Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis.

Authors:  J M Heiple; L Ossowski
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

8.  Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.

Authors:  A Wohlwend; D Belin; J D Vassalli
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.